Middle East and Africa Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ; Functionality ; Type of Formulation

Description

List of Tables

The pharmaceutical excipients market in Middle East and Africa is expected to grow from US$ 402.2 million in 2019 to US$ 571.7 million by 2027; it is estimated to grow at a CAGR of 4.5% 2019-2027. Many blockbuster drugs are on the brink of losing their patents. The patent cliff has resulted in billions of dollars' worth of brand drug sales losing patent protection. Generic drug companies are free to produce their own replicas when patents expire, which can cost up to 80% less than the originals, eventually resulting in a sharp and sudden loss of profits for the companies that developed them. Use of functionality excipients, allows pharmaceutical firms to extend patents. The need to cut prices, generic competition, and lack of innovation are weighing the pharmaceutical industry down. Excipients have become an integral element in the manufacturing of tablets as these provide improved functionality in pharmaceuticals and aid in drug development and innovation, which, in turn help improve patent life at a lower cost. Excipients play a significant role in helping pharmaceutical manufacturers by increasing treatment effectiveness and compliance. Thus, a surge in generics market is expected to drive the pharmaceutical excipients market.

The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals, and other products. In 2019, the organic chemicals segment accounted for the largest share, moreover the same segment is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds, and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.

The growing fear of COVID-19 infection transmission has mandated the development of new guidelines and recommendations by health authorities. South Africa is one of 10 countries involved in an urgent global trial announced by the World Health Organization to identify the most effective treatment for COVID-19. The Regulator, the South African Health Products Regulatory Authority (SAHPRA), has adopted various scientific reviews of new medicines and vaccines through a priority review process. It has also sought to implement a Special Access Program for practitioners treating COVID-19 patients and ensure that a speedy review of clinical trials for new vaccines or repurposed antivirals will be implemented. Further, the National Treasury has issued an instruction note to government departments, municipalities, and entities to help speed up the procurement of goods and commodities required to reduce and control the spread of the virus, which would naturally include medical-related products.

The overall Middle East and Africa pharmaceutical excipients market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the Middle East and Africa pharmaceutical excipients market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Middle East and Africa pharmaceutical excipients market. DuPont de Nemours, Inc.; Ashland Global Holdings, Inc.; BASF SE; Evonik Industries AG; Associated British Foods Plc; Archer Daniels Midland Company; Lubrizol Corporation; and Croda International Plc are among a few players operating in the Middle East and Africa pharmaceutical excipients market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa pharmaceutical excipients market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: TIPRE00022814

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Pharmaceutical Excipients Market - By Product
- 1.3.2 Pharmaceutical Excipients Market - By Functionality
- 1.3.3 Pharmaceutical Excipients Market - By Type of Formulation
- 1.3.4 Middle East and Africa Pharmaceutical Excipients Market - By Country

2. Middle East and Africa Pharmaceutical Excipients Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East and Africa Pharmaceutical Excipients Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Pharmaceutical Excipients Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion

5. Middle East and Africa Pharmaceutical Excipients Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Surge In Generics Market
- 5.1.2 Growth of the Pharmaceutical Market Backed By Multi-Functional Excipients
5.2 Market Restraints
- 5.2.1 Cost and Time Intensive Drug Development Process
5.3 Future Trends
- 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
- 5.3.2 Improving Excipient Capabilities due to Nanotechnology
5.4 Impact Analysis

6. Pharmaceutical Excipients Market - Middle East and Africa Analysis

6.1 Middle East and Africa Pharmaceutical Excipients Market Revenue Forecasts and Analysis

7. Middle East and Africa Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Product

7.1 Overview
7.2 Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)
7.3 Organic Chemicals
- 7.3.1 Overview
- 7.3.2 Organic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
7.4 Inorganic Chemicals
- 7.4.1 Overview
- 7.4.2 Inorganic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
7.5 Other Products
- 7.5.1 Overview
- 7.5.2 Other Products: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

8. Middle East and Africa Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Functionality

8.1 Overview
8.2 Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)
8.3 Fillers And Diluents
- 8.3.1 Overview
- 8.3.2 Fillers and Diluents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.4 Suspending And Viscosity Agents
- 8.4.1 Overview
- 8.4.2 Suspending and Viscosity Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.5 Coating Agents
- 8.5.1 Overview
- 8.5.2 Coating Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.6 Binders
- 8.6.1 Overview
- 8.6.2 Binders: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.7 Preservatives
- 8.7.1 Overview
- 8.7.2 Preservatives: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.8 Emulsifying Agents
- 8.8.1 Overview
- 8.8.2 Emulsifying Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
8.9 Other Functionalities
- 8.9.1 Overview
- 8.9.2 Other Functionalities: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

9. Middle East and Africa Pharmaceutical Excipients Market Analysis and Forecasts to 2027- By Type of Formulation

9.1 Overview
9.2 Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)
9.3 Oral Formulations
- 9.3.1 Overview
- 9.3.2 Oral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
9.4 Topical Formulations
- 9.4.1 Overview
- 9.4.2 Topical Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
9.5 Parenteral Formulations
- 9.5.1 Overview
- 9.5.2 Parenteral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
9.6 Other Formulations
- 9.6.1 Overview
- 9.6.2 Other Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

10. Pharmaceutical Excipients Market Revenue and Forecasts to 2027 - Geographical Analysis

10.1 Middle East & Africa: Pharmaceutical Excipients Market
- 10.1.1 Overview
- 10.1.2 Middle East & Africa: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)
- 10.1.3 Saudi Arabia: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.3.1 Saudi Arabia: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.3.2 Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
  - 10.1.3.3 Saudi Arabia: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
  - 10.1.3.4 Saudi Arabia: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
- 10.1.4 UAE: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.4.1 UAE: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.4.2 UAE: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
  - 10.1.4.3 UAE: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
  - 10.1.4.4 UAE: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
- 10.1.5 South Africa: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.5.1 South Africa: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  - 10.1.5.2 South Africa: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
  - 10.1.5.3 South Africa: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
  - 10.1.5.4 South Africa: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)

11. Impact Of COVID-19 Pandemic on Middle East and Africa Pharmaceutical Excipients Market

11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. COMPANY PROFILES

13.1 DuPont de Nemours, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Ashland Global Holdings Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BASF SE
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Evonik
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Associated British Foods plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Archer Daniels Midland Company
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Lubrizol Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Croda International plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners
14.2 Glossary of Terms